Literature DB >> 7860774

Cell density and paradoxical transcriptional properties of c-Myc and Max in cultured mouse fibroblasts.

L A Lee1, L M Resar, C V Dang.   

Abstract

Deregulated expression of the c-Myc oncoprotein occurs in several human malignancies. The c-Myc protein behaves as a transcription factor, and undoubtedly its role in carcinogenesis involves its ability to affect the expression of genes involved in cell growth. c-Myc has been reported to both activate and repress transcription in transient transfection experiments using reporter constructs bearing multiple copies of the c-Myc binding site, CAC (G/A) TG. We investigated these apparently paradoxical effects of c-Myc by determining if they arose from differences in the cell proliferation states of transfected cells. We found that endogenous c-Myc protein levels vary inversely with the degree of cell confluency, such that at low cell confluency, where endogenous levels of c-Myc are high and presumably endogenous levels of Max are limiting, exogenous c-Myc fails to affect basal transcription. In cells at high cell confluency, in which endogenous c-Myc levels are low, exogenous c-Myc augments transactivation by titrating the relative excess endogenous Max. These observations suggest that the apparently paradoxical behavior of c-Myc in transfection experiments is partially dependent on ambient cellular levels of c-Myc.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7860774      PMCID: PMC295582          DOI: 10.1172/JCI117741

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  38 in total

1.  A point mutation in the MyoD basic domain imparts c-Myc-like properties.

Authors:  M E Van Antwerp; D G Chen; C Chang; E V Prochownik
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-01       Impact factor: 11.205

2.  Mutational analysis of Max: role of basic, helix-loop-helix/leucine zipper domains in DNA binding, dimerization and regulation of Myc-mediated transcriptional activation.

Authors:  C D Reddy; P Dasgupta; P Saikumar; H Dudek; F J Rauscher; E P Reddy
Journal:  Oncogene       Date:  1992-10       Impact factor: 9.867

3.  Mad: a heterodimeric partner for Max that antagonizes Myc transcriptional activity.

Authors:  D E Ayer; L Kretzner; R N Eisenman
Journal:  Cell       Date:  1993-01-29       Impact factor: 41.582

Review 4.  Function of the c-Myc oncoprotein.

Authors:  G J Kato; C V Dang
Journal:  FASEB J       Date:  1992-09       Impact factor: 5.191

5.  Myc and Max proteins possess distinct transcriptional activities.

Authors:  L Kretzner; E M Blackwood; R N Eisenman
Journal:  Nature       Date:  1992-10-01       Impact factor: 49.962

6.  Ornithine decarboxylase activity is critical for cell transformation.

Authors:  M Auvinen; A Paasinen; L C Andersson; E Hölttä
Journal:  Nature       Date:  1992-11-26       Impact factor: 49.962

7.  Role for c-myc in activation-induced apoptotic cell death in T cell hybridomas.

Authors:  Y Shi; J M Glynn; L J Guilbert; T G Cotter; R P Bissonnette; D R Green
Journal:  Science       Date:  1992-07-10       Impact factor: 47.728

8.  Differential modulation of cyclin gene expression by MYC.

Authors:  P Jansen-Dürr; A Meichle; P Steiner; M Pagano; K Finke; J Botz; J Wessbecher; G Draetta; M Eilers
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-15       Impact factor: 11.205

9.  Oncogenic activity of the c-Myc protein requires dimerization with Max.

Authors:  B Amati; M W Brooks; N Levy; T D Littlewood; G I Evan; H Land
Journal:  Cell       Date:  1993-01-29       Impact factor: 41.582

10.  Mxi1, a protein that specifically interacts with Max to bind Myc-Max recognition sites.

Authors:  A S Zervos; J Gyuris; R Brent
Journal:  Cell       Date:  1993-01-29       Impact factor: 41.582

View more
  9 in total

Review 1.  c-Myc target genes involved in cell growth, apoptosis, and metabolism.

Authors:  C V Dang
Journal:  Mol Cell Biol       Date:  1999-01       Impact factor: 4.272

2.  A link between c-Myc-mediated transcriptional repression and neoplastic transformation.

Authors:  L A Lee; C Dolde; J Barrett; C S Wu; C V Dang
Journal:  J Clin Invest       Date:  1996-04-01       Impact factor: 14.808

3.  The HMGA1-COX-2 axis: a key molecular pathway and potential target in pancreatic adenocarcinoma.

Authors:  Joelle Hillion; Shamayra S Smail; Francescopaolo Di Cello; Amy Belton; Sandeep N Shah; Tait Huso; Andrew Schuldenfrei; Dwella Moton Nelson; Leslie Cope; Nathaniel Campbell; Collins Karikari; Abimbola Aderinto; Anirban Maitra; David L Huso; Linda M S Resar
Journal:  Pancreatology       Date:  2012-05-29       Impact factor: 3.996

4.  Paradoxical Behavior of Oncogenes Undermines the Somatic Mutation Theory.

Authors:  Noemi Monti; Roberto Verna; Aurora Piombarolo; Alessandro Querqui; Mariano Bizzarri; Valeria Fedeli
Journal:  Biomolecules       Date:  2022-04-30

5.  Do products of the myc proto-oncogene play a role in transcriptional regulation of the prothymosin alpha gene?

Authors:  P C Mol; R H Wang; D W Batey; L A Lee; C V Dang; S L Berger
Journal:  Mol Cell Biol       Date:  1995-12       Impact factor: 4.272

6.  Variant Max protein, derived by alternative splicing, associates with c-Myc in vivo and inhibits transactivation.

Authors:  M Arsura; A Deshpande; S R Hann; G E Sonenshein
Journal:  Mol Cell Biol       Date:  1995-12       Impact factor: 4.272

7.  Co-emergence and Collapse: The Mesoscopic Approach for Conceptualizing and Investigating the Functional Integration of Organisms.

Authors:  Mariano Bizzarri; Alessandro Giuliani; Andrea Pensotti; Emanuele Ratti; Marta Bertolaso
Journal:  Front Physiol       Date:  2019-07-26       Impact factor: 4.566

8.  β-catenin links cell seeding density to global gene expression during mouse embryonic stem cell differentiation.

Authors:  Lucy LeBlanc; Mijeong Kim; Aparna Kambhampati; Albert J Son; Nereida Ramirez; Jonghwan Kim
Journal:  iScience       Date:  2021-12-01

9.  Heterogeneity of the NIH3T3 Fibroblast Cell Line.

Authors:  Amir Mohammad Rahimi; Mingfang Cai; Sigrid Hoyer-Fender
Journal:  Cells       Date:  2022-08-28       Impact factor: 7.666

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.